PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
27-Nov-2020 Nanoform launches technology for biologics and sets new near-term business target for 2021 Nanoform Finland Plc
27-Nov-2020 Coulter Partners and BioInnovation Institute announce partnership agreement Coulter Partners
27-Nov-2020 Interview Released with Robert Vries, CEO at Hubrecht Organoid Technology speaker at 3D Cell Culture SMi Group
22-Nov-2020 Panel discussion on COVID-19: How has the RNA industry adapted to beat the pandemic SMi Group Ltd
22-Nov-2020 Registration is now open for Pre-filled Syringes East Coast Virtual Conference 2021 SMi Group Ltd
22-Nov-2020 Chairs post an invitation letter for the 15th Annual Parallel Trade conference 2021 SMi Group Ltd
22-Nov-2020 Exclusive interview with Julia Frese, TÜV SÜD released ahead of Pre-filled Syringes Europe SMi Group Ltd
20-Nov-2020 SMi’s 2nd Annual AI in Drug Discovery Announces key industry speakers and agenda released SMi Group
19-Nov-2020 INITIATE CONSULTANCY APPOINT ANDREW MUMFORD AS MANAGING DIRECTOR Initiate Consultancy
19-Nov-2020 One week to go Webinar on Cost-efficient and Green Manufacturing of Peptides thanks to Molecular Hiving™ Technology  SMi Group
16-Nov-2020 UK government’s response to Moderna’s publication of efficacy data for its COVID-19 vaccine gov.uk
16-Nov-2020 AMZELL to initiate FDA-approved Phase 3 trial of innovative injectable treatment for infantile epileptic disease AMZELL B.V
16-Nov-2020 Q BioMed’s Uttroside-B Receives U.S. Patent in Treatment of Liver Cancer Q BioMed Inc
16-Nov-2020 OncoZenge secures approximately SEK 70 million in financing ahead of spin-off and separate listing Moberg Pharma
16-Nov-2020 Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering Envision Pharma Group
16-Nov-2020 Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer Myricx Pharma
16-Nov-2020 Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study Moderna, Inc
16-Nov-2020 Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent Bone Therapeutics
16-Nov-2020 Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases Lead Pharma
16-Nov-2020 FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease Sanofi